Business
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
About this update from Bioaffinity Technologies, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":939,"height":303,"url":"https://media.zenfs.com/en/business-wire.com/65ae081c4a16a968bc8cdf02d7817b7e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LXigKcn9HXyBsck9qNi2hw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMxMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/65ae081c4a16a968bc8cdf02d7817b7e","width":939,"height":303},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/S3d5mCIWvekfU7UBdxkUPg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE4Nzg7aD02MDY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/65ae081c4a16a968bc8cdf02d7817b7e","width":939,"height":303}},"lazy":false},{"type":"text","content":"Case Demonstrates Benefit of Integrating CyPath® Lung into Standard of Care for Patients Under Surveillance After Treatment for Previous Lung Cancer","length":148,"tagName":"p","attribs":{}},{"type":"text","content":"SAN ANTONIO, March 26, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) today released a case study in which a positive CyPath® Lung result led to the detection of a second primary lung cancer in a high-risk patient who was previously diagnosed with stage 1A non-small cell lung cancer and underwent successful surgery in 2023.","length":354,"tagName":"p"},{"type":"text","content":""The CyPath® Lung test provided real-time information that was pivotal in identifying a second primary lung cancer, which might have been missed with standard follow-up protocols," bioAffinity Technologies President and CEO Maria Zannes said. "This case underscores the test's potential to significantly impact patient outcomes by enabling early and accurate detection, especially when imaging reveals small indeterminate nodules that would not immediately lead to invasive diagnostic procedures."","length":521,"tagName":"p"},{"type":"text","content":"The patient is a 72-year-old with a 50 pack-year smoking history and significant COPD and chronic respiratory failure who had a wedge resection to remove a non-small cell lung cancer tumor. Postoperative surveillance included regular computed tomography (CT) scans that revealed changes in the scar tissue, raising concerns about potential recurrence.","length":351,"tagName":"p"},{"type":"text","content":""Subtle chan...